Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Vet Pharmacol Ther ; 34(2): 130-5, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21395603

ABSTRACT

Pharmacokinetics of cefpodoxime in plasma (total concentration) and subcutaneous fluid (free concentration using microdialysis) was investigated in dogs following single oral administration of prodrug cefpodoxime proxetil (equivalent to 5 and 10 mg/kg of cefpodoxime). In a cross over study design, six dogs per dose were utilized after a 1 week washout period. Plasma, microdialysate, and urine samples were collected upto 24 h and analyzed using high performance liquid chromatography. The average maximum concentration (C(max) ) of cefpodoxime in plasma was 13.66 (±6.30) and 27.14 (±4.56) µg/mL with elimination half-life (t(1/2) ) of 3.01 (±0.49) and 4.72 (±1.46) h following 5 and 10 mg/kg dose, respectively. The respective average area under the curve (AUC(0-∞) ) was 82.94 (±30.17) and 107.71 (±30.79) µg·h/mL. Cefpodoxime was readily distributed to skin and average free C(max) in subcutaneous fluid was 1.70 (±0.55) and 3.06 (±0.93) µg/mL at the two doses. Urinary excretion (unchanged cefpodoxime) was the major elimination route. Comparison of subcutaneous fluid concentrations using pharmacokinetic/pharmacodynamic indices of fT(>MIC) indicated that at 10 mg/kg dose; cefpodoxime would yield good therapeutic outcome in skin infections for bacteria with MIC(50) upto 0.5 µg/mL while higher doses (or more frequent dosing) may be needed for bacteria with higher MICs. High urine concentrations suggested cefpodoxime use for urinary infections in dogs.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Ceftizoxime/analogs & derivatives , Dogs/metabolism , Administration, Oral , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/blood , Area Under Curve , Ceftizoxime/administration & dosage , Ceftizoxime/blood , Ceftizoxime/pharmacokinetics , Chromatography, High Pressure Liquid/veterinary , Cross-Over Studies , Dose-Response Relationship, Drug , Half-Life , Injections, Subcutaneous/veterinary , Male , Random Allocation , Cefpodoxime , Cefpodoxime Proxetil
2.
J Pharm Biomed Anal ; 40(2): 443-6, 2006 Feb 13.
Article in English | MEDLINE | ID: mdl-16139980

ABSTRACT

A simple, sensitive and specific agar diffusion bioassay for the antibacterial gatifloxacin was developed using a strain of Bacillus subtilis ATCC 9372 as the test organism. Gatifloxacin could be measured in tablets and raw material at concentration ranging 4-16 microgml(-1). The calibration graph for gatifloxacin was linear from 4.0 to 16.0 microgml(-1). A prospective validation of the method demonstrated that the method was linear (r2=0.9993), precise (R.S.D.=1.14%) and accurate. The results confirmed its precision and did not differ significantly from others methods described in the literature. The validated method yielded good results in terms of the range, linearity, precision, accuracy, specificity and recovery. We concluded that the microbiological assay is satisfactory for in vitro quantification of the antibacterial activity of gatifloxacin.


Subject(s)
Anti-Infective Agents/analysis , Fluoroquinolones/analysis , Pharmaceutical Preparations/chemistry , Agar , Anti-Infective Agents/pharmacology , Bacillus subtilis/drug effects , Bacillus subtilis/growth & development , Diffusion , Dose-Response Relationship, Drug , Fluoroquinolones/pharmacology , Gatifloxacin , Microbial Sensitivity Tests/methods , Reproducibility of Results , Tablets
3.
Int J Pharm ; 264(1-2): 45-55, 2003 Oct 02.
Article in English | MEDLINE | ID: mdl-12972335

ABSTRACT

Gelatin microparticles containing propolis extractive solution (PES) were prepared by spray-drying technique. The optimization of the spray-drying operating conditions and the proportions of gelatin and mannitol were investigated. Regular particle morphology was obtained when mannitol was used, whereas mannitol absence produced a substantial number of coalesced and agglomerated microparticles. Microparticles had a mean diameter of 2.70 microm without mannitol and 2.50 microm with mannitol. The entrapment efficiency for propolis of the microparticles was upto 41% without mannitol and 39% with mannitol. The microencapsulation by spray-drying technique maintained the activity of propolis against Staphylococcus aureus. These gelatin microparticles containing propolis would be useful for developing intermediary or eventual propolis dosage form without the PES' strong and unpleasant taste, aromatic odour, and presence of ethanol.


Subject(s)
Gelatin/chemistry , Propolis/chemistry , Chromatography, High Pressure Liquid , Drug Carriers , Drug Compounding , Mannitol , Microscopy, Electron, Scanning , Particle Size , Propolis/pharmacology , Staphylococcus aureus/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...